Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer

NCT07528209 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

556

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer
pMMR (Microsatellite Stable Rectal Cancer)

Interventions

DRUG: Pucotenlimab combine with CAPOX
DRUG: CAPOX

Sponsor

Sun Yat-sen University